Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-007458

EVP R&D, Chief Medical Officer gave up 5,086 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 16,970 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-20 Option exercise +10,095 27,131 D: show line 1 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-20 Shares withheld for taxes −3,064 $19.58 $59,993 24,067 D: show line 2 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-21 Option exercise +6,875 30,942 D: show line 3 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-21 Shares withheld for taxes −2,022 $19.58 $39,591 28,920 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-20 Option exercise · Restricted Stock Unit Award −10,095 30,287 D: show line 5 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-02-21 Option exercise · Restricted Stock Unit Award −6,875 13,750 D: show line 6 in the form
Loading xslF345X03/form4.xml…